In 2016, Ildong Pharmaceutical Group was restructured into Ildong Holdings, Ildong Pharmaceutical, Ildong Bioscience, Ildong Hyaltech, and others to achieve greater management specialization and efficiency.

As the group’s holdings company, Ildong Holdings is responsible for supporting the group entities in their pursuit of realizing the group’s vision and generating value and for ensuring the continued growth of the group through development of new businesses and injection of fresh capital.
Ildong Holdings also facilitates collaboration between Ildong Pharmaceutical’s pharmaceutical interests, Ildong Bioscience’s probiotics and raw bio materials interests, Ildong Hyaltech’s hyaluronic acid interests, and the interests of other group entities to produce synergistic benefits across all facets of business, including sales and marketing.

With generating greater value for our customers and achieving ever higher levels of innovation and growth as the group’s goals for 2017 and prioritization of quality, innovation of processes, and realization of positive earnings as specific actions that will help us reach those goals, every single member of Ildong Pharmaceutical Group is committed to a year of unprecedented achievements and progress.

Ildong Holdings shares the group’s philosophy of contributing to the health and happiness of humankind and continues to work towards growing as a sustainable and elite organization in pursuit of a balance between value for customers and corporate profits.

• Address2, Baumoe-ro 27-gil, Seocho-gu, Seoul, Republic of Korea
• Tel+82(2)526-3114
• Websitewww.ildongholdings.com